Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Part 2: Potential Alternatives to the Use of Animals in Preclinical Trials

類似資料

• Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is it Time to Rethink Our Current Approach?
  著者:: Van Norman, Gail A.
  出版事項: (2019)
• Phase II Trials in Drug Development and Adaptive Trial Design
  著者:: Van Norman, Gail A.
  出版事項: (2019)
• Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs
  著者:: Van Norman, Gail A.
  出版事項: (2016)
• Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
  著者:: Van Norman, Gail A.
  出版事項: (2016)
• Technology Transfer: From the Research Bench to Commercialization: Part 2: The Commercialization Process
  著者:: Van Norman, Gail A., 等
  出版事項: (2017)